News About: Pharm. Industry
Dongwha to change name to Dongwha Pharm
Dongwha Pharm Ind. changed its name to Dongwha Pharm, the company said in its recent regulatory filing.
The company also said its par value per share will be split from 5,000 won to 1,000 won and as a result, the c...
Chong Kun Dang sees slow Penzal drink sales
Penzal tablet is a very popular pain reliever in the domestic market, but the sales of its drink form is far below the firm's expectation since its launching at the end of last year.
Such a performance is disappoin...
Binex stocks shoot up in July
The stocks of Binex Co. a local biopharmaceutical company, surged as much as 14.7 percent to 18,250 won on July 16 amid optimism that its business will improve as the government’s plan to inject 155 billion won into 2...
Foreign drugmakers utilize KPIC information
The Korea Pharmaceutical Information Service (KPIC) said that multinational companies in Korea tend to utilize more drug distribution related information than Korean companies.
In a briefing session with representa...
Concerns rise among smaller drugmakers
The nation’s small- and medium–sized pharmaceutical companies are struggling to survive from leading pharmaceutical firms taking a stronger hold of the local market with a number of blockbuster generic drugs.
Marke...
Bayer Healthcare release multivitamin effervescent tablets
Bayer Healthcare said it has recently launched Berocca Performance Effervescent Tablets, boosting your energy levels and great for stressed and busy people.
Berocca Performance contains six essential B Group vitami...
FTA will hurt pharmaceutical sector
The successful conclusion of a free trade pact between Korea and the European Union is expected to deal a blow to the local pharmaceutical industry, according to the Korea Pharmaceutical Manufacturers Association.
...
Trade deal will corner local drug makers
Domestic drug makers should be encouraged to focus on research and development of new drugs to survive in an era of the free trade agreements, experts said.
They should pursue the knowledge-intensive industry base...
Choong-wae to conduct large-scale clinical study with pitavastatin
Choong-wae Pharm announced on July 14 that it will conduct the first clinical trial specifically designed to study the efficacy of pitavastatin that may reduce the risk of cardiovascular events in 2,000 Korean patient...
Green Cross holds launching symposium over Abraxane
Green Cross holds launching symposium over Abraxane
Green Cross Corporation held its symposium for Abraxane, paclitaxel protein-bound particles for injectable suspension, at Grand Intercontinental hotel on July 10....
